Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Journal of Cancer Survivorship

Issue 2/2009

Content (7 Articles)

Cancer survivors need evidence on how to optimize physical function

Michael Feuerstein

Skeletal sequelae of cancer and cancer treatment

Charles J. Stava, Camilo Jimenez, Mimi I. Hu, Rena Vassilopoulou-Sellin

Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer

Linda C. Harlan, Carrie N. Klabunde, Anita H. Ambs, Todd Gibson, Leslie Bernstein, Anne McTiernan, Kathleen Meeske, Kathy B. Baumgartner, Rachel Ballard-Barbash

The views of bowel cancer survivors and health care professionals regarding survivorship care plans and post treatment follow up

Carl Baravelli, Meinir Krishnasamy, Carmel Pezaro, Penelope Schofield, Kerryann Lotfi-Jam, Megan Rogers, Donna Milne, Sanchia Aranda, Dorothy King, Beryl Shaw, Suzi Grogan, Michael Jefford

Is somatic comorbidity associated with more somatic symptoms, mental distress, or unhealthy lifestyle in elderly cancer survivors?

Ellen Karine Grov, Sophie D. Fosså, Alv A. Dahl

Emotional distress impacts fear of the future among breast cancer survivors not the reverse

Sophie Lebel, Zeev Rosberger, Linda Edgar, Gerald M. Devins

Problem-solving style and adaptation in breast cancer survivors: a prospective analysis

P. Paul Heppner, Jane M. Armer, Brent Mallinckrodt

Mar 09
Issue: 1/2009
Sep 09
Issue: 3/2009

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits